Human and Mouse ELOX3 Have Distinct Substrate Specificities: Implications for Their Linkage with Lipoxygenases in Skin
Overview
Biophysics
Affiliations
Genetic and biochemical evidence suggests a functional link between human 12R-lipoxygenase (12R-LOX) and epidermal lipoxygenase-3 (eLOX3) in normal differentiation of the epidermis; LOX-derived fatty acid hydroperoxide is isomerized by the atypical eLOX3 into a specific epoxyalcohol that is a potential mediator in the pathway. Mouse epidermis expresses a different complement of LOX enzymes, and therefore this metabolic linkage could differ. To test this concept, we compared the substrate specificities of recombinant mouse and human eLOX3 toward sixteen hydroperoxy stereoisomers of arachidonic and linoleic acids. Both enzymes metabolized R-hydroperoxides 2-3 times faster than the corresponding S enantiomers. Whereas 12R-hydroperoxyeicosatetraenoic acid (12R-HPETE) is the best substrate for human eLOX3 (2.4 s(-1); at 30 microM substrate), mouse eLOX3 shows the highest turnover with 8R-HPETE (2.9 s(-1)) followed by 8S-HPETE (1.3 s(-1)). Novel product structures were characterized from reactions of mouse eLOX3 with 5S-, 8R-, and 8S-HPETEs. 8S-HPETE is converted specifically to a single epoxyalcohol, identified as 10R-hydroxy-8S,9S-epoxyeicosa-5Z,11Z,14Z-trienoic acid. The substrate preference of mouse eLOX3 and the unique occurrence of an 8S-LOX enzyme in mouse skin point to a potential LOX pathway for the production of epoxyalcohol in murine epidermal differentiation.
Revol-Cavalier J, Quaranta A, Newman J, Brash A, Hamberg M, Wheelock C Chem Rev. 2024; 125(1):1-90.
PMID: 39680864 PMC: 11719350. DOI: 10.1021/acs.chemrev.3c00520.
Unveiling ferroptosis: a new frontier in skin disease research.
Wang K, Lin Y, Zhou D, Li P, Zhao X, Han Z Front Immunol. 2024; 15:1485523.
PMID: 39430757 PMC: 11486644. DOI: 10.3389/fimmu.2024.1485523.
Lipoxygenases at the Intersection of Infection and Carcinogenesis.
Amoah A, Pestov N, Korneenko T, Prokhorenko I, Kurakin G, Barlev N Int J Mol Sci. 2024; 25(7).
PMID: 38612771 PMC: 11011848. DOI: 10.3390/ijms25073961.
Noguchi S, Tallman K, Porter N, Stec D, Calcutt M, Boeglin W Biochim Biophys Acta Mol Cell Biol Lipids. 2023; 1868(9):159360.
PMID: 37336389 PMC: 10528070. DOI: 10.1016/j.bbalip.2023.159360.
Korbecki J, Rebacz-Maron E, Kupnicka P, Chlubek D, Baranowska-Bosiacka I Cancers (Basel). 2023; 15(3).
PMID: 36765904 PMC: 9913267. DOI: 10.3390/cancers15030946.